… and develop evidence-based therapeutics through well-designed clinical trials. It … COVID-19
clinical trials landscape. Here, we present our assessment of ongoing COVID-19 therapeutic …

… design targets against pathogenic coronaviruses, particularly Covid-19 as well as past and
recent … review will stimulate development of much needed effective drugs against Covid-19. …

… -originated therapeutics for the treatment of COVID-19. Plant … plant metabolites that have
the therapeutic potential to treat a … , and the mode of therapeutic action; this attempt resulted in …

… of hospitalized patients with COVID-19 pneumonia [Citation33]. … use as a therapeutic
agent against COVID-19. However, … adult patients hospitalized with severe COVID-19 [Citation36]. …

… the COVID-19, we present here a comprehensive review dealing with up-to-date information
of therapeutics or drug regimens being utilized by physicians to treat COVID-19 patients …

… Most of the current COVID-19 antibody therapeutic … of these virus-specific therapeutic
antibodies are in discovery or … class of therapeutics for treating COVID-19 and future coronavirus …

… At present there is an unrealistically high threshold to enter a therapeutic agent into clinical
… medications or comorbidities exclude COVID-19 therapeutics other than a neutralising mAb. …

… the development of therapeutic medications and vaccines to counter COVID-19. …
therapeutic intervention followed by drugs and vaccines currently in clinical trials for COVID-19. …

… Respiratory Syndrome Coronavirus 2 (… as Coronavirus Disease 2019 (COVID-19) [1]. The
high transmissibility and rapid global spread of SARS-CoV-2 has led to a worldwide COVID-19 …

… therapeutics against SARS-COV2. In this retrospective, single-center study, we extracted data
from 122 COVID-19… or had mild symptoms for COVID-19 disease. Of 122 patients 21 (17.21…